Tags

Type your tag names separated by a space and hit enter

Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus.
Neuroendocrinology. 2016; 103(5):476-488.N

Abstract

BACKGROUND/AIMS

Apolipoprotein A-IV (apoA-IV) in the brain potently suppresses food intake. However, the mechanisms underlying its anorexigenic effects remain to be identified.

METHODS

We first examined the effects of apoA-IV on cellular activities in hypothalamic neurons that co-express agouti-related peptide (AgRP) and neuropeptide Y (NPY) and in neurons that express pro-opiomelanocortin (POMC). We then compared anorexigenic effects of apoA-IV in wild-type mice and in mutant mice lacking melanocortin 4 receptors (MC4Rs; the receptors of AgRP and the POMC gene product). Finally, we examined expression of apoA-IV in mouse hypothalamus and quantified its protein levels at fed versus fasted states.

RESULTS

We demonstrate that apoA-IV inhibited the firing rate of AgRP/NPY neurons. The decreased firing was associated with hyperpolarized membrane potential and decreased miniature excitatory postsynaptic current. We further used c-fos immunoreactivity to show that intracerebroventricular (i.c.v.) injections of apoA-IV abolished the fasting-induced activation of AgRP/NPY neurons in mice. Further, we found that apoA-IV depolarized POMC neurons and increased their firing rate. In addition, genetic deletion of MC4Rs blocked anorexigenic effects of i.c.v. apoA-IV. Finally, we detected endogenous apoA-IV in multiple neural populations in the mouse hypothalamus, including AgRP/NPY neurons, and food deprivation suppressed hypothalamic apoA-IV protein levels.

CONCLUSION

Our findings support a model where central apoA-IV inhibits AgRP/NPY neurons and activates POMC neurons to activate MC4Rs, which in turn suppresses food intake.

Authors+Show Affiliations

Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030. Medical College of Qingdao University, Qingdao, China 266020.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030. Department of Physiology, Institute of Animal Science, Southern China University of Agriculture, Guangzhou, China.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030. Department of Rheumatology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, OH, 45237.Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030.Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030. Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26337236

Citation

Yan, Chunling, et al. "Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus." Neuroendocrinology, vol. 103, no. 5, 2016, pp. 476-488.
Yan C, He Y, Xu Y, et al. Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology. 2016;103(5):476-488.
Yan, C., He, Y., Xu, Y., Shu, G., Wang, C., Yang, Y., Saito, K., Xu, P., Hinton, A. O., Yan, X., Yu, L., Wu, Q., Tso, P., Tong, Q., & Xu, Y. (2016). Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology, 103(5), 476-488. https://doi.org/10.1159/000439436
Yan C, et al. Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology. 2016;103(5):476-488. PubMed PMID: 26337236.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. AU - Yan,Chunling, AU - He,Yanlin, AU - Xu,Yuanzhong, AU - Shu,Gang, AU - Wang,Chunmei, AU - Yang,Yongjie, AU - Saito,Kenji, AU - Xu,Pingwen, AU - Hinton,Antentor Othrell,Jr AU - Yan,Xiaofeng, AU - Yu,Likai, AU - Wu,Qi, AU - Tso,Patrick, AU - Tong,Qingchun, AU - Xu,Yong, Y1 - 2015/08/25/ PY - 2015/06/04/received PY - 2015/08/16/accepted PY - 2015/9/5/entrez PY - 2015/9/5/pubmed PY - 2017/5/17/medline SP - 476 EP - 488 JF - Neuroendocrinology JO - Neuroendocrinology VL - 103 IS - 5 N2 - BACKGROUND/AIMS: Apolipoprotein A-IV (apoA-IV) in the brain potently suppresses food intake. However, the mechanisms underlying its anorexigenic effects remain to be identified. METHODS: We first examined the effects of apoA-IV on cellular activities in hypothalamic neurons that co-express agouti-related peptide (AgRP) and neuropeptide Y (NPY) and in neurons that express pro-opiomelanocortin (POMC). We then compared anorexigenic effects of apoA-IV in wild-type mice and in mutant mice lacking melanocortin 4 receptors (MC4Rs; the receptors of AgRP and the POMC gene product). Finally, we examined expression of apoA-IV in mouse hypothalamus and quantified its protein levels at fed versus fasted states. RESULTS: We demonstrate that apoA-IV inhibited the firing rate of AgRP/NPY neurons. The decreased firing was associated with hyperpolarized membrane potential and decreased miniature excitatory postsynaptic current. We further used c-fos immunoreactivity to show that intracerebroventricular (i.c.v.) injections of apoA-IV abolished the fasting-induced activation of AgRP/NPY neurons in mice. Further, we found that apoA-IV depolarized POMC neurons and increased their firing rate. In addition, genetic deletion of MC4Rs blocked anorexigenic effects of i.c.v. apoA-IV. Finally, we detected endogenous apoA-IV in multiple neural populations in the mouse hypothalamus, including AgRP/NPY neurons, and food deprivation suppressed hypothalamic apoA-IV protein levels. CONCLUSION: Our findings support a model where central apoA-IV inhibits AgRP/NPY neurons and activates POMC neurons to activate MC4Rs, which in turn suppresses food intake. SN - 1423-0194 UR - https://www.unboundmedicine.com/medline/citation/26337236/Apolipoprotein_A_IV_Inhibits_AgRP/NPY_Neurons_and_Activates_Pro_Opiomelanocortin_Neurons_in_the_Arcuate_Nucleus_ DB - PRIME DP - Unbound Medicine ER -